C. Male Et Al. , "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.," The Lancet. Haematology , vol.7, 2020
Male, C. Et Al. 2020. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.. The Lancet. Haematology , vol.7 .
Male, C., Lensing, A., Palumbo, J., Kumar, R., Nurmeev, I., Hege, K., ... Bonnet, D.(2020). Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.. The Lancet. Haematology , vol.7.
Male, C Et Al. "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.," The Lancet. Haematology , vol.7, 2020
Male, C Et Al. "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.." The Lancet. Haematology , vol.7, 2020
Male, C. Et Al. (2020) . "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.." The Lancet. Haematology , vol.7.
@article{article, author={C Male Et Al. }, title={Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.}, journal={The Lancet. Haematology}, year=2020}